Entity type
Company
Filer Snapshot
Black Bird Biotech, Inc.
CIK 0001409999. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Total filings
214
Latest filing
16 May 2024
Industry
Miscellaneous Manufacturing Industries
Filing-backed research brief
Start with the SEC data that changes for this CIK
Latest signal: SEC filing timeline only. Each card links back to the PortfolioSavvy page where the filing evidence is closest.
Latest 13F portfolio
—
No parsed 13F portfolio row yet.
Browse latest 13FLargest parsed holding
—
Populates from the latest parsed 13F information table.
Open holding13D/G large stake
—
No recent parsed 13D/G stake row for this CIK.
Browse 13D/GInsider / owner context
—
No parsed Forms 3/4/5 owner position for this CIK.
Browse insider filingsSave this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Source: SEC filing NT 10-Q
View source filing
NT 10-Q filed on 16 May 2024 for CIK 0001409999.
- SEC industry group
- Miscellaneous Manufacturing Industries (Office of Manufacturing)
- Business address
- 11961 Hilltop Road, Suite 22, Argyle, TX, 76226
- Incorporated in
- NV
- Fiscal year end
- 31 December
- Former names on EDGAR
- Digital Development Partners, Inc. (to 21 Jun 2021), Cyprium Resources Inc. (to 12 Aug 2009)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 3 profile fields available
Filer intelligence
What SEC filings say about Black Bird Biotech, Inc.
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
SEC source mix
Counts show available parsed rows, not one combined ownership total.
13F portfolio
No rows yet
Quarterly institutional portfolio holdings.
13D/G stakes
No rows yet
Beneficial ownership and large-stake disclosures.
Forms 3/4/5
No rows yet
Officer, director, and 10% owner holdings or transactions.
No parsed ownership summary yet
We still show the SEC filing timeline below. The intelligence summary will populate when parsed 13F, 13D/G, or Forms 3/4/5 data exists for this CIK.
Latest update
What changed recently for Black Bird Biotech, Inc.
Latest financial period: Q3 2023. Open the source-backed page to inspect the fresh filing or facts context.
Update date
20 Nov 2023
Page type
Company facts
Latest period
Q3 2023
SEC-backed company facts were refreshed from filings filed on 20 Nov 2023.
Benchmark Context
Benchmark context for this company
Black Bird Biotech, Inc. has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.
Compared with
Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.
Why this is notable
Latest financial period: Q3 2023. That gives you a fresh baseline before you compare this company with peers.
- Latest company facts filing date: 20 Nov 2023.
- Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
- Open the facts page first if you want the cleanest path to verification.
Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.
SEC filing record
CIK 0001409999 filing coverage
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
SEC filings
214
First seen
10 Sep 2007
Latest filing
16 May 2024
Entity
Company
Observed form types
NT 10-Q
NT 10-K
SC 14F1
8-K
10-Q
DEF 14C
PRER14C
PRE 14C
424B3
EFFECT
+23 more
CIK-linked evidence first
Industry context: Miscellaneous Manufacturing Industries.
Latest Filings
Showing the latest 12 of 185 SEC filings for Black Bird Biotech, Inc..
NT 10-Q
File 000-52828
FORM NT 10-Q
- Filing date
- 16 May 2024
- Reporting date
- 31 Mar 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
NT 10-K
File 000-52828
NT 10-K
- Filing date
- 01 Apr 2024
- Reporting date
- 31 Dec 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 14F1
File 005-91248
SC 14F1
- Filing date
- 06 Mar 2024
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 000-52828
FORM 8-K
- Filing date
- 05 Mar 2024
- Reporting date
- 01 Mar 2024
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 000-52828
FORM 8-K
- Filing date
- 22 Dec 2023
- Reporting date
- 18 Dec 2023
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-Q
File 000-52828
FORM 10-Q
- Filing date
- 20 Nov 2023
- Reporting date
- 30 Sep 2023
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
NT 10-Q
File 000-52828
NT 10-Q
- Filing date
- 15 Nov 2023
- Reporting date
- 30 Sep 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
10-Q
File 000-52828
FORM 10-Q
- Filing date
- 21 Aug 2023
- Reporting date
- 30 Jun 2023
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
NT 10-Q
File 000-52828
NT 10-Q
- Filing date
- 14 Aug 2023
- Reporting date
- 30 Jun 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
DEF 14C
File 000-52828
DEF 14C
- Filing date
- 01 Jun 2023
- Reporting date
- 31 May 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
10-Q
File 000-52828
FORM 10-Q
- Filing date
- 22 May 2023
- Reporting date
- 31 Mar 2023
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
NT 10-Q
File 000-52828
NT 10-Q
- Filing date
- 15 May 2023
- Reporting date
- 31 Mar 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing